Company / Operating Income per Share
KYNTRA BIO, INC. Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$37.26
FY2025
5-year range
-$37.26 / -$0.98
FY2021-FY2025
Trend
-1040.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income per Share changed -1040% YoY in FY2025, a notable deviation from the 9-year average annual change of -145%.
Based on SEC 10-K filings.
-37.26 in FY2025.
Declined from $-3.06 to $-37.26 over the past 2 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- KYNTRA BIO, INC.'s operating income per share has declined for 4 consecutive years.
- In FY2025, operating income per share decreased 1040.3% year-over-year.
- Peak operating income per share was recorded in FY2018.
Company context
Key Data Points
- Altman Z-Score -3.33 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$37.26 | -1040.3% |
| FY2024 | -$3.27 | -6.6% |
| FY2023 | -$3.06 | -48.3% |
| FY2022 | -$2.07 | -111.5% |
| FY2021 | -$0.98 | +1.2% |
| FY2020 | -$0.99 | +28.0% |
| FY2019 | -$1.37 | -126.3% |
| FY2018 | -$0.61 | +50.3% |
| FY2017 | -$1.22 | -50.8% |
| FY2016 | -$0.81 | -500.4% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026